Ribomic Statistics

Total Valuation

Ribomic has a market cap or net worth of JPY 4.06 billion. The enterprise value is 1.02 billion.

Market Cap	4.06B
Enterprise Value	1.02B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Ribomic has 44.59 million shares outstanding. The number of shares has increased by 13.25% in one year.

Current Share Class	44.59M
Shares Outstanding	44.59M
Shares Change (YoY)	+13.25%
Shares Change (QoQ)	+5.70%
Owned by Insiders (%)	3.87%
Owned by Institutions (%)	4.09%
Float	41.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,925.82
PB Ratio	1.33
P/TBV Ratio	1.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.00
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.99

Financial Position

The company has a current ratio of 22.13

Current Ratio	22.13
Quick Ratio	21.71
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -31.67% and return on invested capital (ROIC) is -20.41%.

Return on Equity (ROE)	-31.67%
Return on Assets (ROA)	-19.50%
Return on Invested Capital (ROIC)	-20.41%
Return on Capital Employed (ROCE)	-34.52%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	24
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, Ribomic has paid 1.21 million in taxes.

Income Tax	1.21M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.23% in the last 52 weeks. The beta is 0.45, so Ribomic's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-3.23%
50-Day Moving Average	88.80
200-Day Moving Average	88.72
Relative Strength Index (RSI)	49.69
Average Volume (20 Days)	376,565

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ribomic had revenue of JPY 2.11 million and -1.02 billion in losses. Loss per share was -25.21.

Revenue	2.11M
Gross Profit	2.11M
Operating Income	-1.05B
Pretax Income	-1.02B
Net Income	-1.02B
EBITDA	-1.05B
EBIT	-1.05B
Loss Per Share	-25.21

Full Income Statement

Balance Sheet

The company has 3.04 billion in cash and n/a in debt, giving a net cash position of 3.04 billion or 68.11 per share.

Cash & Cash Equivalents	3.04B
Total Debt	n/a
Net Cash	3.04B
Net Cash Per Share	68.11
Equity (Book Value)	3.04B
Book Value Per Share	68.26
Working Capital	3.01B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -996.97 million and capital expenditures -32.82 million, giving a free cash flow of -1.03 billion.

Operating Cash Flow	-996.97M
Capital Expenditures	-32.82M
Free Cash Flow	-1.03B
FCF Per Share	-23.09

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-49,861.84%
Pretax Margin	-48,302.28%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ribomic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.25%
Shareholder Yield	n/a
Earnings Yield	-25.11%
FCF Yield	-25.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ribomic has an Altman Z-Score of 13.99 and a Piotroski F-Score of 1.

Altman Z-Score	13.99
Piotroski F-Score	1